Treatment-independent miRNA signature in blood of wilms tumor patients
<p>Abstract</p> <p>Background</p> <p>Blood-born miRNA signatures have recently been reported for various tumor diseases. Here, we compared the miRNA signature in Wilms tumor patients prior and after preoperative chemotherapy according to SIOP protocol 2001.</p> &l...
Main Authors: | Schmitt Jana, Backes Christina, Nourkami-Tutdibi Nasenien, Leidinger Petra, Deutscher Stephanie, Beier Markus, Gessler Manfred, Graf Norbert, Lenhof Hans-Peter, Keller Andreas, Meese Eckart |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Genomics |
Online Access: | http://www.biomedcentral.com/1471-2164/13/379 |
Similar Items
-
Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.
by: Jana Schmitt, et al.
Published: (2011-01-01) -
Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes
by: Nicole Ludwig, et al.
Published: (2016-03-01) -
Towards Clinical Applications of Blood-Borne miRNA Signatures: The Influence of the Anticoagulant EDTA on miRNA Abundance.
by: Petra Leidinger, et al.
Published: (2015-01-01) -
Blood born miRNAs signatures that can serve as disease specific biomarkers are not significantly affected by overall fitness and exercise.
by: Christina Backes, et al.
Published: (2014-01-01) -
Genetic Association With Pseudomonas aeruginosa Acquisition in Cystic Fibrosis: Influence of Surfactant Protein D and Mannose-Binding Lectin
by: Nasenien Nourkami-Tutdibi, et al.
Published: (2021-02-01)